Profile data is unavailable for this security.
About the company
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
- Revenue in INR (TTM)21.72bn
- Net income in INR3.30bn
- Incorporated1995
- Employees4.05k
- LocationDr. Lal PathLabs Ltd12th FloorTower B, SAS Tower, Sector 38, MedicityGURGAON 122001IndiaIND
- Phone+91 1 243016500
- Fax+91 1 244234468
- Websitehttps://www.lalpathlabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Global Enterprises Ltd | 18.56bn | 352.59m | 49.77bn | 5.50k | 141.79 | -- | 25.64 | 2.68 | 2.52 | 2.52 | 132.66 | -- | -- | -- | -- | 3,371,374.00 | -- | -3.20 | -- | -4.35 | 53.21 | 54.19 | 1.27 | -5.21 | -- | 1.30 | -- | -- | 21.27 | 15.28 | -45.38 | 7.42 | -12.26 | -- |
| Vijaya Diagnostic Centre Ltd | 5.14bn | 1.13bn | 70.76bn | 2.00k | 62.82 | -- | 42.69 | 13.78 | 11.01 | 11.01 | 50.08 | -- | -- | -- | -- | 2,573,111.00 | -- | -- | -- | -- | 87.90 | -- | 22.14 | -- | -- | 6.57 | -- | -- | -0.6727 | -- | -22.84 | -- | -- | -- |
| Jupiter Life Line Hospitals Ltd | 10.21bn | 1.47bn | 80.73bn | 3.14k | 50.13 | -- | 42.70 | 7.90 | 24.56 | 24.56 | 166.12 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82.34 | -- | 14.40 | -- | -- | 5.20 | -- | -- | 21.75 | -- | 42.59 | -- | -- | -- |
| Metropolis Healthcare Ltd | 11.59bn | 1.25bn | 90.76bn | 4.29k | 72.90 | -- | 41.84 | 7.83 | 24.30 | 24.30 | 225.81 | -- | -- | -- | -- | 2,702,856.00 | -- | 16.32 | -- | 20.52 | 79.07 | 74.88 | 10.82 | 15.88 | -- | 7.84 | -- | 29.14 | -6.52 | 12.15 | -33.29 | 6.51 | 21.48 | -- |
| Rainbow Children's Medicare Ltd | 12.73bn | 2.20bn | 133.60bn | 3.58k | 60.75 | -- | 41.28 | 10.50 | 21.67 | 21.67 | 125.56 | -- | -- | -- | -- | 3,554,214.00 | -- | -- | -- | -- | 86.95 | -- | 17.37 | -- | -- | 5.67 | -- | -- | 20.52 | -- | 52.48 | -- | -- | -- |
| Krishna Institute Of Medical Sciencs Ltd | 24.40bn | 3.38bn | 161.69bn | 10.00k | 47.84 | -- | 32.41 | 6.63 | 42.24 | 42.24 | 304.98 | -- | -- | -- | -- | 2,440,276.00 | -- | 12.90 | -- | 16.48 | 78.77 | 54.12 | 14.88 | 13.59 | -- | 14.05 | -- | 0.00 | 33.13 | 27.06 | 1.09 | -- | 57.91 | -- |
| Aster DM Healthcare Ltd | 135.05bn | 3.24bn | 182.14bn | 24.65k | 56.18 | -- | 14.11 | 1.35 | 6.51 | 6.51 | 272.61 | -- | -- | -- | -- | 5,478,007.00 | -- | 3.41 | -- | 5.11 | 62.01 | 61.38 | 2.93 | 4.08 | -- | 2.25 | -- | -- | 16.38 | 12.17 | -19.22 | 9.58 | 10.29 | -- |
| Dr. Lal PathLabs Ltd | 21.72bn | 3.30bn | 193.94bn | 4.05k | 58.82 | -- | 40.58 | 8.93 | 39.63 | 39.63 | 261.00 | -- | -- | -- | -- | 5,366,063.00 | -- | 16.20 | -- | 20.00 | 79.36 | 75.58 | 15.35 | 16.01 | -- | 13.68 | -- | 26.75 | -3.38 | 13.80 | -30.74 | 6.94 | -9.27 | 21.67 |
| Narayana Hrudayalaya Ltd | 49.64bn | 7.72bn | 257.24bn | 11.73k | 33.33 | -- | 25.58 | 5.18 | 38.00 | 38.00 | 244.45 | -- | -- | -- | -- | 4,233,245.00 | -- | 7.53 | -- | 9.74 | 61.31 | 45.40 | 15.55 | 6.62 | -- | 10.06 | -- | 10.84 | 22.25 | 14.68 | 77.30 | 63.84 | -- | -- |
| Fortis Healthcare Ltd | 67.50bn | 5.53bn | 335.84bn | 2.98k | 60.79 | -- | 36.81 | 4.98 | 7.32 | 7.32 | 89.37 | -- | -- | -- | -- | 22,688,210.00 | -- | 2.17 | -- | 2.88 | 76.48 | 73.36 | 8.60 | 4.91 | -- | 6.82 | -- | 9.52 | 10.14 | 6.67 | 6.05 | -- | 19.95 | -- |
| Abbott India Ltd | 57.49bn | 11.46bn | 545.56bn | 3.70k | 47.62 | -- | 44.87 | 9.49 | 539.11 | 539.11 | 2,705.32 | -- | -- | -- | -- | 15,536,970.00 | -- | 19.30 | -- | 26.54 | 44.77 | 43.90 | 19.93 | 15.58 | -- | 97.34 | -- | 72.62 | 8.73 | 10.09 | 18.87 | 18.80 | 7.05 | 29.20 |
| Holder | Shares | % Held |
|---|---|---|
| Invesco Advisers, Inc.as of 29 Feb 2024 | 3.39m | 4.06% |
| Wasatch Advisors, Inc.as of 31 Dec 2023 | 2.90m | 3.47% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 2023 | 2.34m | 2.80% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.31m | 1.57% |
| First Sentier Investors (Australia) IM Ltd.as of 31 Dec 2023 | 1.29m | 1.54% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2023 | 1.23m | 1.48% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 31 Mar 2024 | 1.03m | 1.24% |
| First Sentier Investors (Singapore)as of 31 Dec 2023 | 952.63k | 1.14% |
| First Sentier Investors (Hong Kong) Ltd.as of 30 Jun 2023 | 952.63k | 1.14% |
| Al Mehwar Commercial Investments LLCas of 30 Jun 2023 | 882.19k | 1.06% |
